This indicates that TET2 and/or DNMT3A mutations precede RHOA and/or IDH2 mutations in the majority of cases [7], while RHOA G17V is the secondary strike of AITL pathogenic mechanism relay TET2 in early hematopoietic progenitor cell mutation. This evidence concerns the gene TET2 and angioimmunoblastic T-cell lymphoma.